---
title: "C.diff Vaccine in Adults 65 Years of Age and Older"
canonical: "https://www.renown.org/clinical-trials-directory/NCT07282665"
last_updated: "2026-07-22T17:16:29Z"
---

# C.diff Vaccine in Adults 65 Years of Age and Older

URL: https://www.renown.org/clinical-trials-directory/NCT07282665

Short Title: A Study to Learn About a Clostridioides difficile Vaccine in People 65 Years of Age and Older

Enrollment Status: Recruiting

NCT #: [NCT07282665](https://clinicaltrials.gov/study/NCT07282665)

Specialty Area: Infectious Disease

Condition Studied: C.difficile Infection

Age Group: Older Adult

Sex: All

Study Type: Interventional

Accepts Healthy Volunteers: No

Phase: III

Principal Investigator: Samuel Lee MD, Ph.D.

Complete Study Details: https://clinicaltrials.gov/study/NCT07282665

## Study Information

### Summary / Purpose

To evaluate the efficacy, safety, and tolerability of Clostridioides (formerly Clostridium) difficile (C. difficile) adjuvanted vaccine in reducing the incidence of primary C. difficile infection (pCDI) in adults ≥65 years of age

### Who Can Participate

- Adults 65+ years of age
- Increased risk of future development of Clostridoides difficile infection
- No prior episode of C. difficile infection, small- or large bowel resection, metastatic malignancy, or end-state renal disease

### What's Involved

- Random assignment to receive the study medication or placebo given as 2 injections
- Blood and stool samples
- A study electronic diary
- Questionnaires

## Additional Information

Location: Renown Health, Office of Clinical Research

Address: 1500 E 2nd St. Reno, NV 89502

General Research: [775-982-3646](tel:775-982-3646)

Oncology Research: [775-982-5050](tel:775-982-5050)

Email: [Renown-CRD@renown.org](mailto:Renown-CRD@renown.org)
